SEKI, H., SAKURAI, T., MAEDA, Y., OKI, N., AOYAMA, M., YAMAGUCHI, R., . . . SHIMIZU, K. (2019). Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2– Advanced/Metastatic Breast Cancer. In Vivo.
Chicago Stili AlıntıSEKI, HIROHITO, et al. "Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2– Advanced/Metastatic Breast Cancer." In Vivo 2019.
MLA AlıntıSEKI, HIROHITO, et al. "Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2– Advanced/Metastatic Breast Cancer." In Vivo 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..